Frédérique H Vermeij

The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial

Willeke F. Westendorp, Jan‐Dirk Vermeij, Elles Zock et al. · The Lancet · 2015 · 322 citations

Antibiotics, Stroke, Stroke Study +11

Stroke-Associated Infection Is an Independent Risk Factor for Poor Outcome after Acute Ischemic Stroke: Data from the Netherlands Stroke Survey

Frédérique H Vermeij, Wilma J.M. Scholte op Reimer, Peter de Man et al. · Cerebrovascular Diseases · 2009 · 226 citations

Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study

Martijne H.C. Duvekot, Esmée Venema, Anouk D. Rozeman et al. · The Lancet Neurology · 2021 · 191 citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +13

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Christa Walgaard, Bart C. Jacobs, Hester F. Lingsma et al. · The Lancet Neurology · 2021 · 103 citations · Full text

Immunodeficiencies, Immunology, Placebo-controlled Trial +4

Current treatment practice of Guillain-Barré syndrome

Christine Verboon, Alex Y. Doets, Giuliana Galassi et al. · Neurology · 2019 · 87 citations · Full text